SHERIDAN, WYOMING -- June 6, 2026 -- Henry Schein, Inc. has elected William K. "Dan" Daniel as Independent Chairman of the Board effective May 21, 2026, as Stanley M. Bergman steps down following 44 years as a Director of the company. Daniel joined the Henry Schein board in May 2025 and brings executive leadership experience across healthcare and industrial businesses, including a 14-year tenure as Executive Vice President at Danaher Corporation. The election places a leader with direct experience in dental sector governance and operations in the chair role at the world's largest provider of healthcare solutions to office-based dental and medical practitioners. Bergman has been named Chairman Emeritus.
Daniel's Danaher Record Includes Oversight of Its Dental Portfolio and Business Systems
Daniel spent 14 years at Danaher Corporation as Executive Vice President, overseeing multiple business segments including the company's dental portfolio. During that period, he also drove the development of Danaher's internal business systems and organizational culture. When Envista Holdings Corporation was later spun off from Danaher as a standalone dental company, Daniel served on its Board of Directors. Both the operational scale of that role and the dental governance experience it produced overlap directly with Henry Schein's primary markets. He joined the Henry Schein Board of Directors in May 2025, approximately twelve months before being elected Chair.
Daniel described his approach to the role and the foundation he is inheriting:
"I am deeply honored to assume the role of Chairman and am committed to building upon the extraordinary foundation that Stan Bergman and Team Schein established over his tenure. Stan's strategic leadership, sound judgment, and unwavering dedication to Henry Schein's mission have helped shape this company into the leading industry provider of products, services, and technology platforms for healthcare customers. His contributions to shareholders, customers, supplier partners, Team Schein Members, and society are profound and enduring. I look forward to supporting this legacy with the Board as we enter an exciting new chapter of growth."
Bergman Closes a 44-Year Director Tenure and Receives Chairman Emeritus Recognition
Stanley Bergman's exit from the Henry Schein board closes one of the longest director tenures in U.S. healthcare distribution. He served 44 years as a Director and held the Chairman of the Board role before Daniel's election took effect. Henry Schein named him Chairman Emeritus in recognition of that record. Under his leadership, the company grew into a FORTUNE 500 business with operations in 34 countries and annual sales of $13.2 billion in 2025. Revenue has compounded at approximately 11 percent annually since the company went public in 1995. Bergman expressed confidence in Daniel and said he plans to continue supporting Henry Schein's success in the Emeritus capacity.
CEO Fred Lowery Links the Chair Appointment to a Long-Term Integrated Solutions Strategy
Chief Executive Officer Fred Lowery tied the governance transition to Henry Schein's stated commercial direction: developing what the company calls the most trusted and comprehensive platform of integrated solutions in the healthcare industry. He framed Daniel's market knowledge and executive background as directly relevant to executing that strategy. Lowery described Bergman's leadership as transformative over more than four decades and credited it with positioning the company for its current growth trajectory. Improving care quality, practitioner efficiency and patient access are the outcomes the integrated solutions strategy is designed to deliver, according to Lowery's statement.
Chair and CEO Roles Now Operate Separately Under an Independent Governance Structure
With Daniel serving as Independent Chairman and Lowery leading as Chief Executive Officer, Henry Schein now runs under a structure that formally separates board oversight from executive management. That division places independent governance control at board level while keeping day-to-day business decisions with the operating team. Daniel's role is non-executive. Management of the company's $13.2 billion operation remains with Lowery and the senior leadership team.
Henry Schein Distributes More Than 300,000 Products to Over One Million Customers Worldwide
Henry Schein operates a centralized and automated distribution network carrying more than 300,000 branded and corporate brand products from its main distribution centers. More than 25,000 team members worldwide support a global customer base that exceeds one million. That customer base spans office-based dental and medical practices, dental laboratories, government and institutional health clinics and other alternate care sites. Henry Schein is a member of the S&P 500 index and is headquartered in Melville, New York.
Practitioners and procurement decision-makers can find further information on Henry Schein's products, services, and technology platforms at Henry Schein.